Search

Your search keyword '"Czene, K"' showing total 113 results

Search Constraints

Start Over You searched for: Author "Czene, K" Remove constraint Author: "Czene, K" Database OpenAIRE Remove constraint Database: OpenAIRE
113 results on '"Czene, K"'

Search Results

1. FANCM missense variants and breast cancer risk

2. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in similar to 200,000 patients (vol 24, 69, 2022)

3. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

4. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

5. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

6. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

7. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

8. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

9. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer

10. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

11. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

12. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

13. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

14. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

15. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

16. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

17. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

18. Impact of parental cancer on IQ, stress resilience, and physical fitness in young men

19. Shared heritability and functional enrichment across six solid cancers (vol 10, 431, 2019)

20. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

21. Two truncating variants in FANCC and breast cancer risk

22. Genome-wide association study of germline variants and breast cancer-specific mortality

23. Genome-wide association study of germline variants and breast cancer-specific mortality

24. Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

25. Genome-wide association study of germline variants and breast cancer-specific mortality

26. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

27. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

28. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

29. Assessment of Long-term Distant Recurrence-Free Survival Associated with Tamoxifen Therapy in Postmenopausal Patients with Luminal A or Luminal B Breast Cancer

30. DNA mismatch repair gene MSH6 implicated in determining age at natural menopause

31. Identification of nine new susceptibility loci for endometrial cancer

32. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

33. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)

34. Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium\ud

35. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

36. Gene-environment interactions involving functional variants

37. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer

38. Body mass index and breast cancer survival: a Mendelian randomization analysis

39. Body mass index and breast cancer survival:a Mendelian randomization analysis

40. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

41. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

42. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

43. Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation

44. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

45. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

46. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

47. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

48. Five endometrial cancer risk loci identified through genome-wide association analysis

49. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

50. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

Catalog

Books, media, physical & digital resources